Trial Profile
A randomised, double-blinded trial in men with cirrhosis of Testosterone therapy versus placebo to assess the impact on body composition
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Nov 2016
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary) ; Testosterone
- Indications Hormone deficiency
- Focus Therapeutic Use
- 01 Nov 2016 Results assessing published in the Journal of Hepatology
- 13 Jun 2016 Primary endpoint has been met. (Muscle mass =appendicular lean muscle mass (kg) as assessed by body composition component of DEXA (dual energy xray absorptiometry) scanning), as per results published in the Journal of Hepatology.
- 13 Jun 2016 Results published in the Journal of Hepatology